Company intelligence / Profile preview

LINK Medical Research

Ownership: Private
Development stage: Other

Overview

As a full-service Nordic-based CRO and regulatory partner with over 590 clinical trials delivered across more than 20 therapeutic areas and all phases of development. Special expertise in early oncology studies and complex international phase II/III trials. No proprietary clinical results as it does not develop its own drugs.

Therapeutic areas: OncologyEndocrinologyImmunologyOtherDermatologyGastroenterologyNeurologyInfectious Diseases
Industry: Contract Research Organization

Partnerships

Viedoc partnership for eClinical technology solutions

Beyond the preview

Go deeper on LINK Medical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LINK Medical Research.

Explore the full profile